GT
SPPI

Glenmede Trust’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Glenmede Trust’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,824
Closed -$11K – 2405
2020
Q3 		$11K Buy
2,824
+140
+5% +$532 ﹤0.01% 1861
2020
Q2 		$9K Buy
2,684
+1,068
+66% +$3.11K ﹤0.01% 1929
2020
Q1 		$5K Hold
1,616
– – ﹤0.01% 2689
2019
Q4 		$5K Buy
1,616
+1,081
+202% +$8.73K ﹤0.01% 2689
2019
Q3 		$4 Buy
535
+182
+52% +$1.47K ﹤0.01% 2728
2019
Q2 		$3 Hold
353
– – ﹤0.01% 2793
2019
Q1 		$3 Sell
353
-870
-71% -$9.32K ﹤0.01% 2777
2018
Q4 		$10 Sell
1,223
-3,401
-74% -$43.3K ﹤0.01% 2290
2018
Q3 		$76K Buy
4,624
+1,605
+53% +$34.7K ﹤0.01% 1306
2018
Q2 		$63K Buy
+3,019
New +$55.9K ﹤0.01% 1375
2013
Q3 		– Sell
-41,462
Closed -$308K – 2279
2013
Q2 		$308K Buy
+41,462
New +$318K ﹤0.01% 946

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust's SPPI Position: Q4 2020 in Review

Glenmede Trust sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2020, closing a stake of 2,824 shares — an estimated $11K sold.

Glenmede Trust first reported a position in SPPI in Q2 2013 and held it in 11 quarters. The position peaked at $308K in Q2 2013. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Glenmede Trust reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 2,824 Spectrum Pharmaceuticals Inc shares in Q4 2020, an estimated $11K.
  • Glenmede Trust first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Glenmede Trust's Spectrum Pharmaceuticals Inc position peaked at $308K in Q2 2013.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.